On September 9, Eli Lilly announced the launch of TuneLab, an artificial intelligence and machine learning platform that will make its AI drug discovery models, trained on years of research data, available to biotech companies. Eli Lilly stated that the AI models being released this time include proprietary data acquired at a cost of over $1 billion.